Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Meier

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Cellular and Infection Microbiology|December 6, 2021
Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by LyophilizationKai-Thomas Schneider, Toni Kirmann, Esther Veronika Wenzel, et al.
Frontiers in Immunology|October 13, 2023
Antibodies to coagulase of <i>Staphylococcus aureus</i> crossreact to Efb and reveal different binding of shared fibrinogen binding repeatsFederico Bertoglio, Ya-Ping Ko, Sheila Thomas, et al.
Journal of Biotechnology|October 2, 2010
A human scFv antibody generation pipeline for proteome researchMichael Hust, Torsten Meyer, Bernd Voedisch, et al.
Frontiers in Immunology|June 27, 2024
Human antibodies neutralizing the alpha-latrotoxin of the European black widowMaximilian Ruschig, Jana Nerlich, Marlies Becker, et al.
New Biotechnology|December 29, 2015
Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown qualityJanek Kibat, Thomas Schirrmann, Matthias J Knape, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Plant Biotechnology Journal|November 13, 2025
Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European BeechPhilip Alexander Heine, Tetyana Nosenko, Sarah Kistner, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Cellular and Infection Microbiology|December 6, 2021
Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by LyophilizationKai-Thomas Schneider, Toni Kirmann, Esther Veronika Wenzel, et al.
Frontiers in Immunology|October 13, 2023
Antibodies to coagulase of <i>Staphylococcus aureus</i> crossreact to Efb and reveal different binding of shared fibrinogen binding repeatsFederico Bertoglio, Ya-Ping Ko, Sheila Thomas, et al.
Journal of Biotechnology|October 2, 2010
A human scFv antibody generation pipeline for proteome researchMichael Hust, Torsten Meyer, Bernd Voedisch, et al.
Frontiers in Immunology|June 27, 2024
Human antibodies neutralizing the alpha-latrotoxin of the European black widowMaximilian Ruschig, Jana Nerlich, Marlies Becker, et al.
New Biotechnology|December 29, 2015
Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown qualityJanek Kibat, Thomas Schirrmann, Matthias J Knape, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Plant Biotechnology Journal|November 13, 2025
Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European BeechPhilip Alexander Heine, Tetyana Nosenko, Sarah Kistner, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2